A comprehensive view of Diabetes. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

California partners with Civica Rx to manufacture insulin for the state at a cost of US$30 per vial; Civica to make glargine, lispro and aspart at new facility under construction in Petersburg, Virginia
Published: March 20, 2023 by Becker's Hospital Review
Study finds low carb diet based on plant-based foods, not meat or dairy, may extend lifespan of those with type 2 diabetes; CDC reports diabetes affects over 37 million in US, with type 2 diabetes being most common: Diabetes Care
Published: March 20, 2023 by Healthday
American Diabetes Association and Genentech partner to increase screening, treatment for eye health care with pilot program in Birmingham, Alabama; diabetes is leading cause of vision loss in people 18 to 64 years old
Published: March 20, 2023 by American Diabetes Association
FDA drug shortage database shows Novo Nordisk’s Ozempic semaglutide, Lilly’s Mounjaro tirzepatide are once again available; the drugs faced a shortage after becoming popular for their off-label use as weight-loss drugs
Published: March 20, 2023 by FiercePharma
Sanofi to cut price of its Lantus insulin by 78%, short-acting Apidra insulin by 70%, cap out-of-pocket costs for patients with commercial insurance to US$35 starting January 1, 2024
Published: March 16, 2023 by Forbes

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count